D.A. PETERSON FOR TIME

16. William Haseltine
Human Genome Sciences CEO

William Haseltine, 57, combines a passion for scientific exploration and a talent for directing researchers toward practical and profitable products. By investigating the genes most relevant to pharmaceutical research, Human Genome Sciences is transforming itself into the world's first genomics-based pharmaceutical behemoth. It already has six drugs in clinical trials, for diseases including lupus, colitis and several chemotherapy- induced ailments. Haseltine's approach to decoding the genome promises to bring biotech's benefits more quickly to patients and shareholders alike.

CNN Video: Watch a short profile of William Haseltine
Company Web Site: www.hgsi.com

Who would you choose?
Next: Morris Chang >>


Get the Magazine - Try 4 Issues Risk-Free!

QUICK LINKS: Global Influentials Index | Global Business | Business Main | TIME.com Home | CNN.com Home

Copyright © 2001 Time Inc. All rights reserved.
Reproduction in whole or in part without permission is prohibited.

FAQ | Site Map | Privacy Policy | Terms of Use